Epicutaneous immunotherapy for allergic desensitization
Total Trials
19
As Lead Sponsor
17
As Collaborator
2
Total Enrollment
4,145
NCT01170286
Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2010
Completion: Feb 29, 2012
NCT01197053
Epicutaneous Immunotherapy in Peanut Allergy in Children
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2010
Completion: Apr 30, 2015
NCT01675882
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Start: Aug 31, 2012
Completion: Jul 31, 2014
NCT01955109
Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children
Start: Sep 30, 2013
Completion: Sep 30, 2016
NCT02169531
Ex Vivo Immunotherapy for Hyperglycemia in Type 2 Diabetes Mellitus
Start: Mar 31, 2014
Completion: Jan 31, 2016
NCT02223182
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
Phase: Phase 1/2
Start: Nov 30, 2014
Completion: Dec 22, 2020
NCT02579876
Milk Patch for Eosinophilic Esophagitis
Start: Oct 31, 2015
Completion: Nov 20, 2018
NCT02636699
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Phase: Phase 3
Start: Dec 31, 2015
Completion: Aug 18, 2017
NCT03035370
Viaskin Pertussis Vaccine Trial
Start: Sep 5, 2016
Completion: Apr 25, 2018
NCT02916446
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Start: Oct 31, 2016
Completion: Oct 7, 2020
NCT03013517
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Start: Jan 23, 2017
Completion: Mar 31, 2023
NCT03211247
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
Start: Jul 31, 2017
Completion: Apr 27, 2022
NCT03352726
A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
Start: Nov 24, 2017
Completion: Jun 29, 2018
NCT03859700
Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children
Start: Dec 6, 2018
Completion: May 13, 2025
NCT04492683
Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children
Start: Aug 28, 2020
Completion: Mar 31, 2024
NCT05741476
Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
Start: Feb 21, 2023
Completion: Oct 31, 2029
NCT07003919
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
Start: Jun 24, 2025
Completion: May 31, 2028
Loading map...